Ubiquitination/ Proteasome
Research Areas
Products Related to Ubiquitination/ Proteasome(1378)
- GC47193Desethyl Hydroxychloroquine-d4CAS: 1854126-47-8Purity: >99.00%
An internal standard for the quantification of desethyl hydroxychloroquine
- GC47195Desethylchloroquine-d4CAS: 1189971-72-9Purity: >99.00%
An internal standard for the quantification of desethylchloroquine
- GC47303Erlotinib-d6 (hydrochloride)CAS: 1189953-78-3Purity: >99.00%
An internal standard for the quantification of erlotinib
- GC47407Glycochenodeoxycholic Acid (sodium salt hydrate)Purity: >95.00%
A neuropeptide with diverse biological activities
- GC47436HT-2 Toxin-13C22CAS: 1486469-92-4Purity: >98.00%
An internal standard for the quantification of HT-2 toxin
- GC47445Hydroxychloroquine-d4 (sulfate)CAS: 1854126-45-6Purity: >99.00%
An internal standard for the quantification of hydroxychloroquine
- GC47470Isovaleryl-L-carnitine-d3 (chloride)Purity: >99.00%
A neuropeptide with diverse biological activities
- GC47735N-acetyl Desethylchloroquine-d4CAS: 1216619-20-3Purity: >99.00%
An internal standard for the quantification of N-acetyl desethylchloroquine
- GC47965Pomalidomide-d5CAS: 1377838-49-7Purity: >99.00%
An internal standard for the quantification of pomalidomide
- GC48027Rapamycin-d3CAS: 392711-19-2Purity: >≥98% deuterated forms (d1-d3)
An internal standard for the quantification of rapamycin
- GC48052Rilmenidine-d4CAS: 85047-14-9Purity: >99.00%
An internal standard for the quantification of rilmenidine
- GC48118Sunitinib-d10CAS: 1126721-82-1Purity: >99.00%
An internal standard for the quantification of sunitinib
- GC48124Tamoxifen-d5CAS: 157698-32-3Purity: >99.00%
An internal standard for the quantification of tamoxifen
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC47065 | CAY10773 | 1648546-79-5 | >98.00% | |
A derivative of sorafenib | ||||
| GC47193 | Desethyl Hydroxychloroquine-d4 | 1854126-47-8 | >99.00% | |
An internal standard for the quantification of desethyl hydroxychloroquine | ||||
| GC47194 | Desethylchloroquine | 1476-52-4 | >99.00% | |
An active metabolite of chloroquine | ||||
| GC47195 | Desethylchloroquine-d4 | 1189971-72-9 | >99.00% | |
An internal standard for the quantification of desethylchloroquine | ||||
| GC47271 | D-Pyrohomoglutamic Acid | 72002-30-3 | >95.00% | |
A building block | ||||
| GC47284 | Elaidic Acid-d17 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47303 | Erlotinib-d6 (hydrochloride) | 1189953-78-3 | >99.00% | |
An internal standard for the quantification of erlotinib | ||||
| GC47407 | Glycochenodeoxycholic Acid (sodium salt hydrate) | - | >95.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47436 | HT-2 Toxin-13C22 | 1486469-92-4 | >98.00% | |
An internal standard for the quantification of HT-2 toxin | ||||
| GC47445 | Hydroxychloroquine-d4 (sulfate) | 1854126-45-6 | >99.00% | |
An internal standard for the quantification of hydroxychloroquine | ||||
| GC47470 | Isovaleryl-L-carnitine-d3 (chloride) | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47735 | N-acetyl Desethylchloroquine-d4 | 1216619-20-3 | >99.00% | |
An internal standard for the quantification of N-acetyl desethylchloroquine | ||||
| GC47965 | Pomalidomide-d5 | 1377838-49-7 | >99.00% | |
An internal standard for the quantification of pomalidomide | ||||
| GC48027 | Rapamycin-d3 | 392711-19-2 | >≥98% deuterated forms (d1-d3) | |
An internal standard for the quantification of rapamycin | ||||
| GC48052 | Rilmenidine-d4 | 85047-14-9 | >99.00% | |
An internal standard for the quantification of rilmenidine | ||||
| GC48118 | Sunitinib-d10 | 1126721-82-1 | >99.00% | |
An internal standard for the quantification of sunitinib | ||||
| GC48124 | Tamoxifen-d5 | 157698-32-3 | >99.00% | |
An internal standard for the quantification of tamoxifen | ||||
| GC48406 | PSI (trifluoroacetate salt) | - | >95.00% | |
A proteasome inhibitor | ||||
| GC48410 | VH 032 Linker 3 (hydrate) | - | >95.00% | |
A VHL ligand 1 derivative | ||||
| GC48614 | IMP-1710 | 2383117-96-0 | >98.00% | |
A clickable UCH-L1 inhibitor | ||||
| GC48676 | Monascuspiloin | 1011244-19-1 | >85.00% | |
A fungal metabolite with anticancer activity | ||||
| GC48689 | SBP-7455 | 1884222-74-5 | >98.00% | |
A dual inhibitor of ULK1 and ULK2 | ||||
| GC49016 | Dimethyl 2-ketoglutarate | 13192-04-6 | >97.50% | |
An esterified form of α-ketoglutarate | ||||
| GC49084 | PHY34 | 2130033-55-3 | >98.00% | |
An inhibitor of late-stage autophagy | ||||